
Kuehn Law, PLLC is investigating whether certain officers and directors of TG Therapeutics, Inc. breached their fiduciary duties through potential self-dealing. This legal probe could lead to damages for shareholders and corporate governance reforms. Long-term shareholders are encouraged to contact the law firm for a free consultation as there may be limited time to act. The investigation highlights concerns about management integrity and shareholder rights at TG Therapeutics.